Fineschi M, Bravi A, Gori T. The, “slow coronary flow” phenomenon: evidence of preserved coronary flow reserve despite increased resting microvascular resistances. Int J Cardiol. 2008;127(3):358–61.
PubMed
Google Scholar
Wang X, Nie SP. The coronary slow flow phenomenon: characteristics, mechanisms and implications. Cardiovasc Diagn Ther. 2011;1(1):37–43.
PubMed
PubMed Central
Google Scholar
Arbel Y, Rind E, Banai S, et al. Prevalence and predictors of slow flow in angiographically normal coronary arteries. Clin Hemorheol Microcirc. 2012;52(1):5–14.
PubMed
Google Scholar
Rao VSK, Garre I. Predictors of coronary slow flow phenomenon: a retrospective study. Ind J Car Dis Wom. 2019;4:85–91.
Google Scholar
Hawkins BM, Stavrakis S, Rousan TA, Abu-Fadel M, Schechter E. Coronary slow flow–prevalence and clinical correlations. Circ J. 2012;76(4):936–42.
PubMed
Google Scholar
Manjunath CN, Rawal JR, Irani PM, Madhu K. Atherogenic dyslipidemia. Indian J Endocrinol Metab. 2013;17(6):969–76.
PubMed
PubMed Central
CAS
Google Scholar
Padró T, Vilahur G, Badimon L. Dyslipidemias and microcirculation. Curr Pharm Des. 2018;24(25):2921–6.
PubMed
Google Scholar
Gradinaru D, Borsa C, Ionescu C, Prada GI. Oxidized LDL and NO synthesis–biomarkers of endothelial dysfunction and ageing. Mech Ageing Dev. 2015;151:101–13.
PubMed
CAS
Google Scholar
Tran-Dinh A, Diallo D, Delbosc S, et al. HDL and endothelial protection. Br J Pharmacol. 2013;169(3):493–511.
PubMed
PubMed Central
CAS
Google Scholar
Kajikawa M, Higashi Y. Triglycerides and endothelial function: molecular biology to clinical perspective. Curr Opin Lipidol. 2019;30(5):364–9.
PubMed
CAS
Google Scholar
Ye X, Kong W, Zafar MI, Chen LL. Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Cardiovasc Diabetol. 2019;18(1):48.
PubMed
PubMed Central
Google Scholar
Dobiásová M, Frohlich J, Sedová M, Brown BG. Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography. J Lipid Res. 2011;52(3):566–71.
PubMed
PubMed Central
Google Scholar
Bhardwaj S, Bhattacharjee J, Bhatnagar MK, Tyagi S. Atherogenic index of plasma, Castelli risk index and atherogenic coefficient- new parameters in assessing cardiovascular risk. Int J Pharm Bio Sci. 2013;3:359–64.
Google Scholar
Nair D, Carrigan TP, Curtin RJ, et al. Association of total cholesterol/high-density lipoprotein cholesterol ratio with proximal coronary atherosclerosis detected by multislice computed tomography. Prev Cardiol. 2009;12(1):19–26.
PubMed
Google Scholar
Millán J, Pintó X, Muñoz A, et al. Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag. 2009;5:757–65.
PubMed
PubMed Central
Google Scholar
Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996;93(5):879–88.
PubMed
CAS
Google Scholar
Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39.e14.
PubMed
Google Scholar
Cin VG, Pekdemir H, Camsari A, et al. Diffuse intimal thickening of coronary arteries in slow coronary flow. Japan Heart J. 2003;44:907–19.
Google Scholar
Pekdemir H, Cin VG, Ciçek D, et al. Slow coronary flow may be a sign of diffuse atherosclerosis. Contribution of FFR and IVUS. Acta Cardiol. 2004;59(2):127–33.
PubMed
Google Scholar
Ding YD, Pei YQ, et al. Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow. BMC Cardiovasc Disord. 2020;20(1):248.
PubMed
PubMed Central
CAS
Google Scholar
Musunuru K. Atherogenic dyslipidemia: cardiovascular risk and dietary intervention. Lipids. 2010;45(10):907–14.
PubMed
PubMed Central
CAS
Google Scholar
Ivanova EA, Myasoedova VA, Melnichenko AA, Grechko AV, Orekhov AN. Small dense low-density lipoprotein as biomarker for atherosclerotic diseases. Oxid Med Cell Longev. 2017;2017:1273042.
PubMed
PubMed Central
Google Scholar
Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res. 2002;43(9):1363–79.
PubMed
CAS
Google Scholar
Kathiresan S, Otvos JD, Sullivan LM, et al. Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation. 2006;113(1):20–9.
PubMed
CAS
Google Scholar
Hoogeveen RC, Gaubatz JW, Sun W, et al. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Arterioscler Thromb Vasc Biol. 2014;34(5):1069–77.
PubMed
PubMed Central
CAS
Google Scholar
Lawler PR, Akinkuolie AO, Chu AY, et al. Atherogenic lipoprotein determinants of cardiovascular disease and residual risk among individuals with low low-density lipoprotein cholesterol. J Am Heart Assoc. 2017;6(7):e005549.
PubMed
PubMed Central
Google Scholar
Liou L, Kaptoge S. Association of small, dense LDL-cholesterol concentration and lipoprotein particle characteristics with coronary heart disease: a systematic review and meta-analysis. PLoS ONE. 2020;15(11):e0241993.
PubMed
PubMed Central
CAS
Google Scholar
Zhu X, Yu L, Zhou H, et al. Atherogenic index of plasma is a novel and better biomarker associated with obesity: a population-based cross-sectional study in China. Lipids Health Dis. 2018;17(1):37. https://doi.org/10.1186/s12944-018-0686-8.
Article
PubMed
PubMed Central
CAS
Google Scholar
Moriyama K. The association between the triglyceride to high-density lipoprotein cholesterol ratio and low-density lipoprotein subclasses. Intern Med. 2020;59(21):2661–9.
PubMed
PubMed Central
CAS
Google Scholar
Caselli C, De Caterina R, Smit JM, et al. Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina. Sci Rep. 2021;11(1):20714.
PubMed
PubMed Central
CAS
Google Scholar
Wang L, Chen F, Xiaoqi C, Yujun C, Zijie L. Atherogenic index of plasma is an independent risk factor for coronary artery disease and a higher SYNTAX score. Angiology. 2021;72(2):181–6.
PubMed
CAS
Google Scholar
Bendzala M, Sabaka P, Caprnda M, et al. Atherogenic index of plasma is positively associated with the risk of all-cause death in elderly women: a 10-year follow-up. Wien Klin Wochenschr. 2017;129(21–22):793–8.
PubMed
Google Scholar
Cai G, Liu W, Lv S, et al. Gender-specific associations between atherogenic index of plasma and the presence and severity of acute coronary syndrome in very young adults: a hospital-based observational study. Lipids Health Dis. 2019;18:99.
PubMed
PubMed Central
Google Scholar
Fernández-Macías JC, Ochoa-Martínez AC, Varela-Silva JA, Pérez-Maldonado IN. Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses. Arch Med Res. 2019;50(5):285–94.
PubMed
Google Scholar
Johnston N, Jernberg T, Lagerqvist B, Siegbahn A, Wallentin L. Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers. Am J Cardiol. 2006;97(5):640–5.
PubMed
CAS
Google Scholar
Fujihara K, Suzuki H, Sato A, et al. Carotid artery plaque and LDL-to-HDL cholesterol ratio predict atherosclerotic status in coronary arteries in asymptomatic patients with type 2 diabetes mellitus. J Atheroscler Thromb. 2013;20(5):452–64.
PubMed
CAS
Google Scholar
Bleda S, de Haro J, Varela C, Esparza L, Rodriguez J, Acin F. Improving total-cholesterol/HDL-cholesterol ratio results in an endothelial dysfunction recovery in peripheral artery disease patients. Cholesterol. 2012;2012:895.
Google Scholar
Kıs M, Soydan E, Akın M. The relationship between endothelial functions and HDL/LDL ratios in patients with coronary artery disease. EJCM. 2020;8(4):199–205.
Google Scholar
Niu H, Wei Z, Zhang Y, He J, Jia D. Atorvastatin improves coronary flow and endothelial function in patients with coronary slow flow. Exp Ther Med. 2018;15(1):904–8.
PubMed
CAS
Google Scholar
Kalaycı B, Kalaycı S, Köktürk F. Proportional serum lipid parameters in coronary slow flow phenomenon. Turkiye Klinikleri J Cardiovasc Sci. 2019;31(1):21–8.
Google Scholar
Sanghvi S, Mathur R, Baroopal A, Kumar A. Clinical, demographic, risk factor and angiographic profile of coronary slow flow phenomenon: a single centre experience. Indian Heart J. 2018;70(3):S290–4.
PubMed
PubMed Central
Google Scholar
Erbay AR, Turhan H, Senen K, et al. Documentation of slow coronary flow by the thrombolysis in myocardial infarction frame count in habitual smokers with angiographically normal coronary arteries. Heart Vessels. 2004;19(6):271–4.
PubMed
Google Scholar
Messner B, Bernhard D. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol. 2014;34(3):509–15.
PubMed
CAS
Google Scholar
Aksan G, Soylu K, Aksoy O, et al. The relationship between neutrophil gelatinase-associated lipocalin levels and the slow coronary flow phenomenon. Coron Artery Dis. 2014;25(6):505–59.
PubMed
Google Scholar
Soylu K, Gulel O, Yucel H, et al. The effect of blood cell count on coronary flow in patients with coronary slow flow phenomenon. Pak J Med Sci. 2014;30(5):936–41.
PubMed
PubMed Central
Google Scholar
Turhan H, Saydam GS, Erbay AR. Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow. Int J Cardiol. 2006;108:224–30.
PubMed
Google Scholar
Leonardi S, Gragnano F, Carrara G, et al. Prognostic implications of declining hemoglobin content in patients hospitalized with acute coronary syndromes. J Am Coll Cardiol. 2021;77(4):375–88.
PubMed
CAS
Google Scholar
Oylumlu M, Adnan Doğan A, Oylumlu M, et al. Relationship between platelet-to-lymphocyte ratio and coronary slow flow. Anatol J Cardiol. 2015;15(5):391–5.
PubMed
CAS
Google Scholar
Doğan M, Akyel A, Çimen T, et al. Relationship between neutrophil to lymphocyte ratio and slow coronary flow. Clin Appl Thromb Hemost. 2015;21(3):251–4.
PubMed
Google Scholar
Slavka G, Perkmann T, Haslacher H, et al. Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease. Arterioscler Thromb Vasc Biol. 2011;31(5):1215–8.
PubMed
CAS
Google Scholar
Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest. 2005;115(12):3378–84.
PubMed
PubMed Central
CAS
Google Scholar